This dual role aligns with our findings: the loss of CAV1 in RB and spindle/myxoid melanoma suggests a tumor-suppressor role in less aggressive settings, while its gain in epithelioid melanoma points to its pro-metastatic activity. Here, CAV1 is linked to epithelioid cell melanoma.